CAS No.:101-99-5

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	350mg/kg (350mg/kg)		"Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59Vol. 5, Pg. 45, 1959.
mouse	LD50	intravenous	400mg/kg (400mg/kg)		"Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59Vol. 5, Pg. 45, 1959.
mouse	LDLo	subcutaneous	1gm/kg (1000mg/kg)	behavioral: somnolence (general depressed activity)	"Pharmakologische Prufung von Analgetika, Dissertation," Herrlen, G., Pharmakologischen Institut der Universitat Tubingen, Fed. Rep. Ger., 1933Vol. -, Pg. -, 1933.
rat	LDLo	unreported	500mg/kg (500mg/kg)	behavioral: somnolence (general depressed activity) vascular: regional or general arteriolar or venous dilation	British Journal of Pharmacology and Chemotherapy. Vol. 7, Pg. 142, 1952.

Consensus Reports：

Reported in EPA TSCA Inventory.

SAFETY PROFILE：

Poison by intraperitoneal and intravenous routes. Moderately toxic by subcutaneous and possibly other routes. Questionable carcinogen with experimental neoplastigenic data. When heated to decomposition it emits toxic fumes of NO_x. See also CARBAMATES. 
Hazard Codes:
Xn
Risk Statements:
R40:Limited evidence of a carcinogenic effect. 
Safety Statements:
S36/37:Wear suitable protective clothing and gloves.
RTECS: FD8925000

Standards and Recommendations：

 

Analytical Methods：